Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasm Female × Patient Reported Outcome Measures × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Breast Neoplasms 4 Leukemia 3 Carcinoma, Non-Small-Cell Lung 3 Radiation Injuries 2 Preleukemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Multiple Chronic Conditions 2 Lymphoproliferative Disorders 2 Lymphoma 2 Lymphatic Diseases 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid 2 Leukemia, Lymphoid 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Diseases 2 Esophageal Neoplasms 2 Cognitive Dysfunction 2 Brain Neoplasms 2 Bone Marrow Diseases 2 Thoracic Neoplasms 1

Interventions

Fulvestrant 2 venetoclax 1 pyrotinib 1 pertuzumab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06080607 2024-03-25

PRO

Regina Elena Cancer Institute

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡